Category: Vaccines

FDA Authorizes Updated Novavax COVID-19 Vaccine

Posted on by

October 3, 2023. Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA COVID-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two doses. Read More

Updated COVID-19 Vaccine Availability Expected Within Next Week

Posted on by

DOVER, Del. (Sept. 15, 2023) –  This week, the Centers for Disease Control and Prevention (CDC) issued the recommendation that everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter.  The recommendation follows the Food and Drug Administration’s (FDA) action approving and authorizing for emergency use updated COVID-19 vaccines from Pfizer/BioNTech and Moderna formulated to more closely target currently circulating variants.  Per the CDC, vaccination remains the best protection against COVID-19-related hospitalization and death and reduces the chance of suffering from Long COVID.  Anyone who has yet to receive any type of Read More …

FDA Approves Updated COVID-19 Vaccines

Posted on by

Yesterday, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Read More

FDA Approves Maternal RSV Vaccine

Posted on by

August 21, 2023. Fenit Nirappil, Washington Post Federal regulators on Monday approved a maternal RSV vaccine administered during pregnancy to protect infants from severe illness. It’s the latest in a new arsenal of immunizations against the common respiratory virus that is the leading cause of hospitalization in young children and kills thousands of seniors annually. Read more.

August is National Immunization Awareness Month!

Posted on by

National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the importance of routine vaccination for people of all ages. Use these resources to help you discuss routine vaccinations with your patients and parents during NIAM and throughout the year. Check out the toolkit here!

Improving the Vaccine Experience

Posted on by

Free, 1-hour webinar hosted by ImmunizeOrg, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults” at 1 p.m. ET on Feb 28. Anxiety about needles and injections affects as many as 2 out of 3 children and 1 out of 4 adults; this anxiety can contribute to dreading, delaying, or avoiding vaccinations, even when the importance of preventing illness is understood. The good news is that there are safe, effective, and practical steps that those who administer vaccines and vaccine recipients or their caregivers can take to reduce vaccination-related pain and anxiety and increase confidence in vaccination. Read More …

National Vaccination Coverage Among Adolescents, 2021

Posted on by

The CDC has just released the National Vaccination Coverage Among Adolescents Aged 13-17 Years, 2021.  “Among adolescents aged 13–17 years in 2021, HPV vaccination coverage (≥1 dose and HPV vaccine up to date) increased. Coverage with ≥1-dose Tdap and ≥1-dose MenACWY remained high. Among age-eligible adolescents, MenACWY booster dose coverage increased. Analyses of the potential COVID-19 pandemic effect among adolescents born in 2008 show a concerning decrease in ≥1 MenACWY and ≥1 Tdap dose coverage.”  Read more

CDC Raises Delaware’s COVID-19 Community Levels to High in All Counties

Posted on by

CDC RAISES DELAWARE’S COVID-19 COMMUNITY LEVELS TO HIGH IN ALL COUNTIES; DPH ENCOURAGES MASKING IN INDOOR PUBLIC SETTINGS AND VACCINATION DOVER, DE (July 29, 2022) – The Centers for Disease Control and Prevention (CDC) raised Delaware’s COVID-19 community levels to the High category (red) in all three counties on July 28, 2022.    As a result, the Division of Public Health (DPH) is asking Delawareans to follow the CDC’s key strategies at this level of community spread:    ·       Wear a well-fitting mask in indoor public settings, regardless of vaccination status. ·       Stay home if you are sick and get tested if you have symptoms or Read More …

DPH Encourages Eligible Delawareans to Get Boosted Now

Posted on by

DOVER, DE (July 15, 2022) – The Delaware Division of Public Health (DPH) reports that COVID-19 cases experienced an uptick in the daily 7-day average for the percentage of positive tests since the previous monthly COVID-19 update released on June 17, 2022. Since that time, Delaware has also exceeded 3,000 COVID-related deaths. According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, which was last updated on June 14, case levels in Kent County are considered high, while case levels in New Castle and Sussex Counties are listed as medium. Many people are expressing concerns about getting vaccinated Read More …